ASCAT 2023 | The Lancet Commision on SCD: global strategies to improve outcomes
Miguel Abboud
• 27 Oct 2023
Miguel Abboud, MD, American University of Beirut Medical Center, Beirut, Lebanon, speaks on the Lancet commission on sickle cell disease (SCD), which aims to define global strategies to improve outcomes in SCD, and highlights two of the five sections of the report with which he is most closely involved. This interview was recorded at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
